High resolution MRI anatomy of the cat brain at 3Tesla

Journal of Neuroscience Methods

Volumn 227, Issue , 2014, Pages 10-17

  Gray Edwards, Heather L ^a   Salibi, Nouha ^b   Josephson, Eleanor M ^a   Hudson, Judith A ^a   Cox, Nancy R ^a   Randle, Ashley N ^a   McCurdy, Victoria J ^a   Bradbury, Allison M ^a   Wilson, Diane U ^a   Beyers, Ronald J ^c   Denney, Thomas S ^c   Martin, Douglas R ^a  

^a AUBURN UNIVERSITY   (United States)

^b SIEMENS CORPORATE RESEARCH   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Animal model; Brain; Cat; Central nervous system; MRI; Translational

Indexed keywords

ADULT; ANATOMICAL CONCEPTS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; BRAIN PYRAMID; BRAIN REGION; CEREBELLUM NUCLEUS; COCHLEA; CONTROLLED STUDY; CRANIAL NERVE; DENTATE NUCLEUS; DORSAL PLANE; EXPERIMENTAL CAT; FASTIGIAL CEREBELLAR NUCLEI; FEMALE; HIGH RESOLUTION NUCLEAR MAGNETIC RESONANCE IMAGING; HISTOLOGY; INFERIOR COLLICULUS; INTERPOSITUS NUCLEUS; LATERAL GENICULATE BODY; MALE; MIDDLE CEREBRAL ARTERY; NEUROANATOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECUNEUS; PRIORITY JOURNAL; RETICULAR FORMATION; ROSTRAL CEREBRAL ARTERY; SAGITTAL PLANE; SPINOCEREBELLAR TRACT; T ONE WEIGHTED THREE DIMENSIONAL MAGNETIZATION PREPARED RAPID GRADIENT ECHO SEQUENCE IMAGE; T TWO WEIGHTED TURBO SPIN ECHO IMAGE; TEMPORAL LOBE; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSVERSE PLANE; VESTIBULAR NUCLEUS; ANATOMY AND HISTOLOGY; ANIMAL; BRAIN; CAT; PROCEDURES; THREE DIMENSIONAL IMAGING;

ANIMALS; BRAIN; CATS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84896837901     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2014.01.035     Document Type: Article

References (67)

1. Abramo F., Bo S., Canese M.G., Poli A. Regional distribution of lesions in the central-nervous-system of cats infected with feline immunodeficiency virus. AIDS Res Hum Retroviruses 1995, 11:1247-1253.
2. Alvarez-Linera J. 3T MRI: advances in brain imaging. Eur J Radiol 2008, 67:415-426.
3. Aye M.M., Izumo S., Inada S., Isashiki Y., Yamanaka H., Matsumuro K., et al. Histopathological and ultrastructural features of feline hereditary cerebellar cortical atrophy: a novel animal model of human spinocerebellar degeneration. Acta Neuropathol (Berl) 1998, 96:379-387.
4. Ba-Ssalamah A., Nobauer-Huhmann I.M., Pinker K., Schibany N., Prokesch R., Mehrain S., et al. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol 2003, 38:415-422.
5. Baker H.J., Lindsey J.R., McKhann G.M., Farrell D.F. Neuronal GM1 gangliosidosis in a Siamese cat with beta-galactosidase deficiency. Science 1971, 174:838-839.
6. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., et al. Feline immunodeficiency virus - an interesting model for aids studies and an important cat pathogen. Clin Microbiol Rev 1995, 8:87-112.
7. Berman A. The thalamus and basal telencephalon of the cat: a cytoarchitectonic atlas with stereotaxic coordinates. 1982, University of Wisconsin Press, Madison, WI.
8. Berman A., Jones E.G. The brain stem of the cat: a cytoarchitectonic atlas with steriotaxic coordinates. 1968, University of Wisconsin Press, Madison, WI.
9. Bleier R. The hypothalamus of the cat 1961, Johns Hopkins Press, Baltimore, MD.
10. Bote R.P., Blazquez-Llorca L., Fernandez-Gil M.A., Alonso-Nanclares L., Munoz A., De Felipe J. Hippocampal sclerosis: histopathology substrate and magnetic resonance imaging. Semin Ultrasound CT MR 2008, 29:2-14.
11. Bradbury A.M., Cochran J.N., McCurdy V.J., Johnson A.K., Brunson B.L., Gray-Edwards H., et al. Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy. Mol Ther 2013, 21:1306-1315.
12. Bradbury A.M., Morrison N.E., Hwang M., Cox N.R., Baker H.J., Martin D.R. Neurodegenerative lysosomal storage disease in European Burmese cats with hexosaminidase beta-subunit deficiency. Mol Genet Metab 2009, 97:53-59.
13. Bradbury A.M., McCurdy V.J., Johnson A.K., Gray-Edwards H., Brunson B.L., Randle A.N., et al. Intracranial AAV gene therapy extends the life span of GM2 gangliosidosis cats >4 four-fold with no clinical evidence of vector toxicity. Mol Ther 2013, 21:226.
14. Bucher T., Colle M.A., Wakeling E., Dubreil L., Fyfe J., Briot-Nivard D., et al. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease. Hum Gene Ther 2013, 24:670-682.
15. Burditt L.J., Chotai K., Hirani S., Nugent P.G., Winchester B.G., Blakemore W.F. Biochemical studies on a case of feline mannosidosis. Biochem J 1980, 189:467-473.
16. Buxton D.F., Compton R.W. The canine brain: basic atlas for an auto-tutorial approach to the central nervous system 1986.
17. Candolfi M., Curtin J.F., Nichols W.S., Muhammad A.G., King G.D., Pluhar G.E., et al. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol 2007, 85:133-148.
18. Casal M., Haskins M. Large animal models and gene therapy. Eur J Hum Genet 2006, 14:266-272.
19. Cork L.C., Munnell J.F., Lorenz M.D. The pathology of feline GM2 gangliosidosis. Am J Pathol 1978, 90:723-734.
20. Cork L.C., Munnell J.F., Lorenz M.D., Murphy J.V., Baker H.J., Rattazzi M.C. GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency. Science 1977, 196:1014-1017.
21. Costa L.F., Paixao T.A., Tsolis R.M., Baumler A.J., Santos R.L. Salmonellosis in cattle: advantages of being an experimental model. Res Vet Sci 2012, 93:1-6.
22. Duewell S., Wolff S.D., Wen H., Balaban R.S., Jezzard P. MR imaging contrast in human brain tissue: assessment and optimization at 4T. Radiology 1996, 199:780-786.
23. Dyce K.M., Sack W.O., Wensing C.J.G. Textbook of veterinary anatomy: elsevier science health science division 2009.
24. Ellinwood N.M., Vite C.H., Haskins M.E. Gene therapy for lysosomal storage diseases: the lessons and promise of animal models. J Gene Med 2004, 6:481-506.
25. Eskandari R., Harris C.A., McAllister J.P. Reactive astrocytosis in feline neonatal hydrocephalus: acute, chronic, and shunt-induced changes. Childs Nerv Syst 2011, 27:2067-2076.
26. Fatouros P.P., Marmarou A. Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. J Neurosurg 1999, 90:109-115.
27. Gitzelmann R., Bosshard N.U., Superti-Furga A., Spycher M.A., Briner J., Wiesmann U., et al. Feline mucopolysaccharidosis VII due to beta-glucuronidase deficiency. Vet Pathol 1994, 31:435-443.
28. Hasegawa D., Yamato O., Kobayashi M., Fujita M., Nakamura S., Takahashi K., et al. Clinical and molecular analysis of GM2 gangliosidosis in two apparent littermate kittens of the Japanese domestic cat. J Feline Med Surg 2007, 9:232-237.
29. Haskins M.E., Jezyk P.F., Desnick R.J., McDonough S.K., Patterson D.F. Alpha-l-iduronidase deficiency in a cat: a model of mucopolysaccharidosis I. Pediatr Res 1979, 13:1294-1297.
30. Haskins M.E., Jezyk P.F., Desnick R.J., Patterson D.F. Animal model of human disease: mucopolysaccharidosis VI maroteaux-lamy syndrome arylsulfatase B-deficient mucopolysaccharidosis in the Siamese cat. Am J Pathol 1981, 105:191-193.
31. Hein W.R., Griebel P.J. A road less travelled: large animal models in immunological research. Nat Rev Immunol 2003, 3:79-84.
32. Hilton D.L., Einhaus S.L., Meric A.L.3rd, White R.P., Schweitzer J.B., Park M.R., et al. Early assessment of neurologic deficits in the fluid percussion model of brain injury. J Neurotrauma 1993, 10:121-133.
33. International Committee of Veterinary Gross Anatomical Nomenclature (I.C.V.G.A.N.) Nomina anatomica veterinaria 2005, Electronic format posted on the Web site of World Association of Veterinary Anatomists, Hannover/Columbia MO/Ghent/Sapporo. 5th ed.
34. Johansen-Berg H., Behrens T.E.J. Diffusion MRI: from quantitative measurement to in-vivo neuroanatomy 2009, Elsevier Science, London.
35. Johnson A.K., McCurdy V.J., Bradbury A.M., Gray-Edwards H., Randle A.N., Huang M., et al. AAV gene therapy normalizes disease phenotype and extends lifespan >4 fold in feline GM1 gangliosidosis. Mol Ther 2013, 21:226.
36. Khan T., Havey R.M., Sayers S.T., Patwardhan A., King W.W. Animal models of spinal cord contusion injuries. Lab Anim Sci 1999, 49:161-172.
37. Knake S., Triantafyllou C., Wald L.L., Wiggins G., Kirk G.P., Larsson P.G., et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology 2005, 65:1026-1031.
38. Kroll R.A., Pagel M.A., Roman-Goldstein S., Barkovich A.J., D'Agostino A.N., Neuwelt E.A. White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities. AJNR Am J Neuroradiol 1995, 16:1219-1226.
39. Kuhl C.K., Textor J., Gieseke J., von Falkenhausen M., Gernert S., Urbach H., et al. Acute and subacute ischemic stroke at high-field-strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study. Radiology 2005, 234:509-516.
40. Lee S.K., Kim D.I., Kim S.Y., Kim D.J., Lee J.E., Kim J.H. Reperfusion cellular injury in an animal model of transient ischemia. AJNR Am J Neuroradiol 2004, 25:1342-1347.
41. Lowenthal A.C., Cummings J.F., Wenger D.A., Thrall M.A., Wood P.A., de Lahunta A. Feline sphingolipidosis resembling Niemann-Pick disease type C. Acta Neuropathol (Berl) 1990, 81:189-197.
42. Martin D.R., Krum B.K., Varadarajan G.S., Hathcock T.L., Smith B.F., Baker H.J. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant. Exp Neurol 2004, 187:30-37.
43. McCurdy V.J., Gary-Edwards H.L., Randle A.N., Bradbury A.M., Johnson A.K., Beadlescomb P.M., et al. Dramatic phenotypic improvement after adeno-associated virus gene therapy in a feline model of sandhoff disease. Mol Ther 2013, 21:15.
44. Meurens F., Summerfield A., Nauwynck H., Saif L., Gerdts V. The pig: a model for human infectious diseases. Trends Microbiol 2012, 20:50-57.
45. Mogicato G., Conchou F., Layssol-Lamour C., Raharison F., Sautet J. Normal feline brain: clinical anatomy using magnetic resonance imaging. Anat Histol Embryol 2012, 41:87-95.
46. Ohshima T., Murray G.J., Swaim W.D., Longenecker G., Quirk J.M., Cardarelli C.O., et al. alpha-Galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci U S A 1997, 94:2540-2544.
47. Phaneuf D., Wakamatsu N., Huang J.Q., Borowski A., Peterson A.C., Fortunato S.R., et al. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 1996, 5:1-14.
48. Podell M., Hadjiconstantinou M., Smith M.A., Neff N.H. Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism. Exp Neurol 2003, 179:159-166.
49. Podell M., March P.A., Buck W.R., Mathes L.E. The feline model of neuroAIDS: understanding the progression towards AIDS dementia. J Psychopharmacol 2000, 14:205-213.
50. Sawaishi Y., Sasaki M., Yano T., Hirayama A., Akabane J., Takada G. A hippocampal lesion detected by high-field 3 tesla magnetic resonance imaging in a patient with temporal lobe epilepsy. Tohoku J Exp Med 2005, 205:287-291.
51. Schaller O., Constantinescu G.M. Illustrated veterinary anatomical nomenclature 2007, Enke, Ferdinand.
52. Schneider J.S., Yuwiler A., Markham C.H. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry. Exp Neurol 1986, 91:293-307.
53. Singer M. The brain of the dog in section 1962, W.B. Saunders Company, Philadelphia.
54. Smits M., Kovacs S., de Ridder D., Peeters R.R., van Hecke P., Sunaert S. Lateralization of functional magnetic resonance imaging (fMRI) activation in the auditory pathway of patients with lateralized tinnitus. Neuroradiology 2007, 49:669-679.
55. Snider R., Niemer W.T. A stereotaxic atlas of the cat brain 1970, University of Chicago Press, Chicago, IL.
56. Strong A.J., Anderson P.J., Watts H.R., Virley D.J., Lloyd A., Irving E.A., et al. Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain 2007, 130:995-1008.
57. Suzuki K. Genetic galactosylceramidase deficiency (globoid cell leukodystrophy Krabbe disease) in different mammalian species. Neurochem Pathol 1985, 3:53-68.
58. Takahashi M., Uematsu H., Hatabu H. MR imaging at high magnetic fields. Eur J Radiol 2003, 46:45-52.
59. Toyota S., Graf R., Valentino M., Yoshimine T., Heiss W.D. Malignant infarction in cats after prolonged middle cerebral artery occlusion: glutamate elevation related to decrease of cerebral perfusion pressure. Stroke 2002, 33:1383-1391.
60. Vinogradov E., Degenhardt A., Smith D., Marquis R., Vartanian T.K., Kinkel P., et al. High-resolution anatomic, diffusion tensor, and magnetization transfer magnetic resonance imaging of the optic chiasm at 3T. J Magn Reson Imaging 2005, 22:302-306.
61. Vite C.H., Magnitsky S., Aleman D., O'Donnell P., Cullen K., Ding W., et al. Apparent diffusion coefficient reveals gray and white matter disease, and T2 mapping detects white matter disease in the brain in feline alpha-mannosidosis. AJNR Am J Neuroradiol 2008, 29:308-313.
62. Vite C.H., McGowan J.C., Braund K.G., Drobatz K.J., Glickson J.D., Wolfe J.H., et al. Histopathology, electrodiagnostic testing, and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha-mannosidosis. J Neuropathol Exp Neurol 2001, 60:817-828.
63. Vite C.H., McGowan J.C., Niogi S.N., Passini M.A., Drobatz K.J., Haskins M.E., et al. Effective gene therapy for an inherited CNS disease in a large animal model. Ann Neurol 2005, 57:355-364.
64. Vite C.H., Passini M.A., Haskins M.E., Wolfe J.H. Adeno-associated virus vector-mediated transduction in the cat brain. Gene Ther 2003, 10:1874-1881.
65. Vite C.H., Wang P., Patel R.T., Walton R.M., Walkley S.U., Sellers R.S., et al. Biodistribution and pharmacodynamics of recombinant human alpha-l-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations. Mol Genet Metab 2011, 103:268-274.
66. Wattjes M.P., Harzheim M., Kuhl C.K., Gieseke J., Schmidt S., Klotz L., et al. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR imaging criteria for multiple sclerosis?. AJNR Am J Neuroradiol 2006, 27:1794-1798.
67. Woermann F.G., Vollmar C. Clinical MRI in children and adults with focal epilepsy: a critical review. Epilepsy Behav 2009, 15:40-49.